Cancer metastasis is the main cause of death in
cancer patients; however, there is currently no effective method to predict and prevent
metastasis of
gastric cancer. Therefore, gaining an understanding of the molecular mechanism of
tumor metastasis is important for the development of new drugs and improving the survival rate of patients who suffer from
gastric cancer.
Sinulariolide is an active compound isolated from the cultured soft coral Sinularia flexibilis. We employed
sinulariolide and
gastric cancer cells in experiments such as MTT, cell migration assays, cell invasion assays, and Western blotting analysis. Analysis of cell migration and invasion capabilities showed that the inhibition effects on cell
metastasis and invasion increased with
sinulariolide concentration in AGS and NCI-N87 cells. Immunostaining analysis showed that
sinulariolide significantly reduced the
protein expressions of MMP-2, MMP-9, and uPA, but the expressions of
TIMP-1 and
TIMP-2 were increased, while FAK, phosphorylated PI3K, phosphorylated AKT, phosphorylated mTOR, phosphorylated JNK, phosphorylated p38MAPK, and phosphorylated ERK decreased in expression with increasing
sinulariolide concentration. From the results, we inferred that
sinulariolide treatment in AGS and NCI-N87 cells reduced the activities of MMP-2 and MMP-9 via the FAK/PI3K/AKT/mTOR and MAPKs signaling pathways, further inhibiting the invasion and migration of these cells. Moreover,
sinulariolide altered the
protein expressions of
E-cadherin and
N-cadherin in the cytosol and Snail in the nuclei of AGS and NCI-N87 cells, which indicated that
sinulariolide can avert the EMT process. These findings suggested that
sinulariolide is a potential chemotherapeutic agent for development as a new drug for the treatment of
gastric cancer.